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Abstract
A series of novel 5-substituted isoxazolidine derivatives 3a(i/viii), 3b(i/viii) and 3c(i/viii) have been prepared and their antifungal
activity on Aspergillus flavus , Fusarium moniliforme and Botrydiplodia theobromae have been evaluated.
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1. Introduction
Over the past two decades the frequency of systematic
fungal infection in man has increased dramatically.
Ketoconazole was the first orally active antifungal agent
that was effective against a broad array of systematic
and superficial fungal infections [1]. In addition to azole
derivatives, a number of antifungal agents having
chemical structures other than azoles have recently
been introduced to the clinic.
In previous studies [2,3], we have described the
application of 1,3-dipolar cycloaddition reaction to the
synthesis of biologically active compounds. We recog-
nized an opportunity to apply our knowledge of 1,3-
dipolar species to the synthesis of a series of 5-
substituted isoxazolidine compounds through the 1,3-
dipolar cycloaddition reaction of a-substituted aldoni-
trones and monosubstituted alkenes. The resulting 5-
substituted isoxazolidines were expected to differ in their
chemical and antifungal properties from the known
azole derivatives, thus providing valuable information
of a new generation of antifungal agents.
2. Chemistry
Compounds 2(a/c) were prepared by the reduction of
nitro compounds and 4-biphenyl carboxaldehyde with
zinc dust using histidine as catalyst as shown in Fig. 1
[4]. The nitrones were found to be light sensitive [5] and
hygroscopic [6]. Hence, they were stored in the dark
until further use. The nitrones are versatile synthetic
intermediates in organic synthesis [7,8]. Recently, we
reported that nitrones are convenient class of com-
pounds used for synthesis of ultimate carcinogens [9/11]
which are biologically interesting molecules. The novel
isoxazolidines 3(a/c) were obtained by refluxing the
nitrones 2(a/c) with equimolar amount of monosub-
stituted alkene in toluene/xylene. The cycloaddition of
all monosubstituted olefins with nitrone showed high
regioselectivity and gave 5-substituted derivatives pre-
dominantly major products [12] for both electron
donating and electron withdrawing groups.
3. Results and discussion
The major products of 5-substituted isoxazolidine
derivatives 3(a/c) were separated on silica gel column
using appropriate combination of chloroform, hexane,
benzene and petroleum ether as eluent. The reaction
condition and the physical data of cycloadducts are
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given in Table 1. All the synthesized isoxazolidines were
structurally characterized by IR, 1H-NMR and C, H, N
analysis. The antifungal activity of these new com-
pounds were evaluated in solid agar media, and their
antifungal activity are summarized in Table 2. Some
compounds 3b(ii), 3b(iv), 3b(vi) 3c(ii), and 3c(vi) were
shown more potent than nystatin. In general, 3c(i/viii)
showed better activity than 3a(i/viii) and 3b(i/viii). The
introduction of fluorine to the phenyl ring enhanced the
antifungal activity. However, introduction of one more
phenyl ring to the isoxazolidine ring in 3b(ii) and 3c(ii)
increasing the antifungal activity and the introduction of
methylene hydroxy group in 3b(vi) and 3c(vi) of
isoxazolidine enhancing the antifungal activity.
4. Conclusion
We prepared a novel series of 5-substituted isoxazo-
lidines. Some of these compounds possessed good
antifungal activities against the fungus Aspergillus
flavus , Fusarium moniliforme and Botrydiplodia theo-
bromae .
5. Experimental
5.1. Chemistry
The melting points were determined on SELACO-650
hot stage apparatus and are uncorrected. IR (Nujol)
spectra were measured on shimadzu 8300 IR spectro-
photometer, 1H-NMR were recorded on Shimadzu
AMX 400-Bruker, 400 MHz spectrophotometer by
using CDCl3 as solvent and TMS as an internal
standard (chemical shift in d ppm). Elemental analyses
(C, H, N) were obtained on a Vario-EL instrument. The
results were within 9/0.4% of the theoretical values.
Column and TLC were done with silica gel BDH 60/
120 mesh and pre-coated silica gel plates.
Fig. 1.
Table 1
Reaction condition and physical data of isoxazolidines 3a(i/vii), 3b(i/vii) and 3c(i-viii) series
Isoxazolidines Solvent used for reaction Time taken to complete the reaction (h) Rf value Eluent used in separation % Yield M.p. (8C)
3a(i) toluene 17 0.61 CHCl3/hexane 1:2 57 oily
3a(ii) toluene 17 0.63 CHCl3/hexane 1:2 61 141
3a(iii) toluene 18 0.58 CHCl3/petroleum ether 2:1 54 oily
3a(iv) toluene 18 0.54 CHCl3/petroleum ether 2:1 84 oily
3a(v) toluene 31 0.68 CHCl3/petroleum ether 2:1 69 oily
3a(vi) toluene 22 0.58 CHCl3/petroleum ether 2:1 58.6 oily
3a(vii) toluene 20 0.62 CHCl3/petroleum ether 2:1 62 oily
3a(viii) toluene 18 0.64 CHCl3/hexane 1:2 68 oily
3b(i) toluene 19 0.62 CHCl3/hexane 1:2 69.5 oily
3b(ii) toluene 24 0.64 CHCl3/hexane 1:2 71.5 134
3b(iii) toluene 19 0.61 CHCl3/hexane 1:2 65 oily
3b(iv) toluene 20 0.58 CHCl3/petroleum ether 1:1 84 oily
3b(v) toluene 24 0.67 CHCl3/petroleum ether 2:1 80 oily
3b(vi) toluene 17 0.69 CHCl3/petroleum ether 2:1 65.5 oily
3b(vii) toluene 22 0.62 CHCl3/petroleum ether 2:1 61.5 oily
3b(viii) toluene 18 0.66 CHCl3/petroleum ether 2:1 64 oily
3c(i) xylene 20 0.77 CHCl3/benzene (2:1) 65 oily
3c(ii) xylene 19 0.86 CHCl3/benzene (2:1) 60 132
3c(iii) xylene 20 0.63 CHCl3/benzene (3:1) 59 oily
3c(iv) xylene 22 0.71 CHCl3/petroleum ether (3:1) 61 oily
3c(v) xylene 24 0.69 CHCl3/benzene (2:1) 62.8 oily
3c(vi) xylene 24 0.68 CHCl3/petroleum ether (2:1) 59.6 oily
3c(vii) xylene 23 0.79 CHCl3/benzene (1:1) 66.4 oily
3c(viii) xylene 22 0.66 CHCl3/benzene (3:1) 58 oily
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General procedure for the synthesis of isoxazolidines,
3a(i/viii), 3b(i/vii) and 3c(i/viii): Equimolar mixture of
nitrones 2a, 2b and 2c and different alkenes were
dissolved in 10 mL of toluene/xylene. The reaction
mixture was refluxed for 18/20 h to complete the
reaction, which was monitored by TLC. The pure
products were separated by using appropriate mixture
of chloroform, hexane, petroleum ether and benzene as
eluent in silica gel column.
5.1.1. Synthesis of C-biphenyl-N-phenyl nitrone (2a)
This was obtained from the reduction of a mixture of
nitrobenzene and 4-biphenyl carboxaldehyde with zinc
dust using histidine as catalyst [4]. A white crystalline
solid is obtained in ethanol; yield 748 mg (80%), m.p.
203 8C.
1H-NMR d (ppm): 7.39/7.51 (m, 6H, Ar/H), 7.65/
7.48 (m, 6H, Ar/H), 7.97 (s, 1H, CH/N), 8.46/8.51
(dd, 2H, Ar/H).
IR (Nujol): n (cm1): 1584 (C/N); 1168 (NO).
5.1.2. Synthesis of C-biphenyl-N-(4-
methoxyphenyl)nitrone (2b)
This was obtained from the reduction of a mixture of
4-methoxynitrobenzene and 4-biphenyl carboxaldehyde
with zinc dust using histidine as catalyst. A white
crystalline solid is obtained in ethanol; yield 815 mg
(95%), m.p. 178 8C.
1H-NMR d (ppm): 3.82 (s, 3H, Ar/OCH3); 7.20/7.24
(d, 2H, Ar/H); 7.34/7.46 (m, 3H, Ar/H), 7.62/7.72
(m, 6H, Ar/H), 7.92 (s, 1H, CH/N), 8.24/8.28 (d, 2H,
Ar/H).
IR (Nujol): n (cm1): 1572 (C/N); 1152 (NO).
5.1.3. Synthesis of C-biphenyl-N-(4-
fluorophenyl)nitrone (2c)
This was obtained from the reduction of a mixture of
4-fluoronitrobenzene and 4-biphenyl carboxaldehyde
with zinc dust using histidine as catalyst [4]. A white
crystalline solid is obtained in ethanol; yield 812 mg
(96%), m.p. 307 8C.
1H-NMR d (ppm): 7.44/7.49 (m, 5H, Ar/H), 7.65/
7.79 (m, 6H, Ar/H), 7.94 (s, 1H, CH/N), 8.44/8.48 (d,
2H, Ar/H).
IR (Nujol): n (cm1): 1572 (C/N); 1152 (NO).
5.1.4. Synthesis of 2-phenyl-3-biphenyl-5-cyano
isoxazolidine (3a(i))
This was obtained from equimolar mixture of C -(4-
biphenyl)-N -phenylnitrone (2a) (500 mg) and acryloni-
trile (0.10 mL).
1H-NMR d (ppm): 2.65/2.81 (dd, 2H, H4); 4.45 (t,
1H, H5); 5.08 (t, 1H, H3); 6.91 (t, 1H, Ar/H); 7.2 (t, 2H,
Table 2
The minimum inhibitory concentrations (MIC) a of isoxazolidines 3a(i/viii), 3b(i/viii) and 3c(i/viii) for antifungal activity
Isoxazolidines Tested fungus
A. flavus (MIC in mM) F. moniliforme (MIC in mM) B. theobromae (MIC in mM)
Nystatin 3 5 2.5
3a(i) 12.0 12.0 11.5
3a(ii) 5.5 10.5 5.5
3a(iii) 7.0 5.0 9.5
3a(iv) 10.5 10.5 5.5
3a(v) 8.0 8.0 11.0
3a(vi) 12.0 3.5 12.0
3a(vii) 5.5 10.5 5.5
3a(viii) 11.5 5.5 11.5
3b(i) 8.5 8.5 7.5
3b(ii) 2.5 5.0 5.0
3b(iii) 4.5 6.5 7.0
3b(iv) 2.5 6.0 9.0
3b(v) 6.5 7.5 7.5
3b(vi) 3.0 3.0 5.5
3b(vii) 7.5 10.0 7.5
3b(viii) 5.5 9.0 6.5
3c(i) 9.0 7.5 8.5
3c(ii) 2.5 5.5 5.0
3c(iii) 5.5 7.0 6.0
3c(iv) 4.0 5.5 7.5
3c(v) 8.0 6.5 9.0
3c(vi) 3.0 3.0 6.0
3c(vii) 5.0 5.5 7.5
3c(viii) 8.0 6.5 8.0
a Average of atleast three determinations.
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Ar/H); 7.41 (d, 2H, Ar/H(BP); 7.52 (t, 1H, Ar/H(BP);
7.64 (t, 2H, Ar/H(BP); 7.72 (d, 2H, Ar/H); 7.69 (d, 4H,
Ar/H(BP).
IR (Nujol): n (cm1): 1742 (CO); 1280 (NO).
5.1.5. Synthesis of 2-phenyl-3-biphenyl-5-phenyl
isoxazolidine (3a(ii))
This was obtained from equimolar mixture of C -(4-
biphenyl)-N -phenylnitrone (2a) (500 mg) and styrene
(0.25 mL).
1H-NMR d (ppm): 2.72/2.88 (dd, 2H, H4); 5.05 (t,
1H, H5); 5.12 (t, 1H, H3); 6.91 (t, 1H, Ar/H); 7.2 (t, 2H,
Ar/H); 7.29/7.41 (m, 5H, Ar/H); 7.42 (d, 2H, Ar/
H(BP); 7.52 (t, 1H, Ar/H(BP); 7.64 (t, 2H, Ar/
H(BP); 7.72 (d, 2H, Ar/H); 7.69 (d, 4H, Ar/H(BP).
IR (Nujol): n (cm1): 1712 (CO); 1240 (NO).
5.1.6. Synthesis of 2-phenyl-3-biphenyl-5-benzoate
isoxazolidine (3a(iii))
This was obtained from equimolar mixture of C -(4-
biphenyl)-N -phenylnitrone (2a) (500 mg) and vinyl
benzoate (0.25 mL).
1H-NMR d (ppm): 2.70/2.86 (dd, 2H, H4); 4.72 (t,
1H, H5); 5.13 (t, 1H, H3); 6.91 (t, 1H, Ar/H); 7.20 (t,
2H, Ar/H); 7.28/7.50 (m, 3H, Ar/H); 7.41 (d, 2H, Ar/
H(BP); 7.52 (t, 1H, Ar/H(BP); 7.72 (d, 2H, Ar/H); 7.64
(t, 2H, Ar/H(BP); 7.79 (d, 4H, Ar/H(BP); 7.81 (d, 2H,
Ar/H).
IR (Nujol): n (cm1): 1748 (C/O); 1730 (CO); 1260
(NO).
5.1.7. Synthesis of 2-phenyl-3-biphenyl-5-ethylate
isoxazolidine (3a(iv))
This was obtained from equimolar mixture of C -(4-
biphenyl)-N -phenylnitrone (2a) (500 mg) and ethyl
acrylate (0.20 mL).
1H-NMR d (ppm): 0.94 (t, 3H, CH3); 2.68/2.86 (dd,
2H, H4); 3.62 (q, 2H, CH2); 4.43 (t, 1H, H5); 5.12 (t, 1H,
H3); 6.91 (t, 1H, Ar/H); 7.2 (t, 2H, Ar/H); 7.41 (d, 2H,
Ar/H, BP); 7.52 (t, 1H, Ar/H, BP); 7.64 (t, 2H, Ar/H,
BP); 7.72 (d, 2H, Ar/H); 7.79 (d, 4H, Ar/H, BP).
IR (Nujol): n (cm1): 1720 (C/O); 1722 (CO); 1234
(NO).
5.1.8. Synthesis of 2-phenyl-3-biphenyl-5-methylene
acetate isoxazolidine (3a(v))
This was obtained from equimolar mixture of C -(4-
biphenyl)-N -phenylnitrone (2a) (500 mg) and allyl
acetate (0.2 mL).
1H-NMR d (ppm): 2.42 (d, 2H, CH2) 2.62/2.78 (dd,
2H, H4); 3.42 (s, 3H, OCH3); 2.70/4.25 (m, 1H, H5);
5.06 (t, 1H, H3) 6.91 (t, 1H, Ar/H); 7.2 (t, 2H, Ar/H);
7.41 (d, 2H, Ar/H, BP); 7.52 (t, 1H, Ar/H, BP); 7.64 (t,
2H, Ar/H, BP); 7.72 (d, 2H, Ar/H); 7.69 (d, 4H, Ar/H,
BP).
IR (Nujol): n (cm1): 1745 (CO); 1270 (NO).
5.1.9. Synthesis of 2-phenyl-3-biphenyl-5-methelene
hydroxy isoxazolidine (3a(vi))
This was obtained from equimolar mixture of C -(4-
biphenyl)-N -phenylnitrone (2a) (500 mg) and allyl
alcohol (0.12 mL).
1H-NMR d (ppm): 2.65/2.80 (dd, 2H, H4); 3.64 (d,
2H, CH2); 4.76 (m, 1H, H5); 5.14 (t, 1H, H3); 5.25 (s,
1H, OH); 6.92 (t, 1H, Ar/H); 7.2 (t, 2H, Ar/H); 7.41 (d,
2H, Ar/H, BP); 7.52 (t, 1H, Ar/H, BP); 7.64 (t, 2H,
Ar/H, BP); 7.72 (d, 2H, Ar/H); 7.69 (d, 4H, Ar/H,
BP).
IR (Nujol): n (cm1): 1710 (CO); 1242 (NO).
5.1.10. Synthesis of 2-phenyl-3-biphenyl-5-(3-
cyclohexene) isoxazolidine (3a(vii))
This was obtained from equimolar mixture of C -(4-
biphenyl)-N -phenylnitrone (3a) (500 mg) and 4-vinyl-1-
cyclohexene (0.25 mL).
1H-NMR d (ppm): 1.38/1.42 (m, 2H, CH2, cyclohex-
ene); 1.52 (s, 1H, cyclohexene); 2.27/2.31 (m, 2H,
cyclohexene); 2.33/2.38 (m, 2H, cyclohexene); 2.6/
2.65/2.80 (dd, 2H, H4); 3.64 (d, 2H, CH2); 4.76 (t,
1H, H5); 5.14 (t, 1H, H3); 4.82 (m, 1H, CH); 5.12 (t, 1H,
CH); 5.6/5.66 (m, 2H, cyclohexene); 6.92 (t, 1H, Ar/
H); 7.2 (t, 2H, Ar/H); 7.41 (d, 2H, Ar/H, BP); 7.52 (t,
1H, Ar/H, BP); 7.64 (t, 2H, Ar/H, BP); 7.72 (d, 2H,
Ar/H); 7.79 (d, 4H, Ar/H, BP).
IR (Nujol): n (cm1): 1730 (CO); 1262 (NO).
5.1.11. Synthesis of 2-phenyl-3-biphenyl-5-methylate
isoxazolidine (3a(viii))
This was obtained from equimolar mixture of C -(4-
biphenyl)-N -phenylnitrone (3a) (500 mg) and methyl
acrylate (0.17 mL).
1H-NMR d (ppm): 2.6/2.9 (dd, 2H, CH2); 3.41 (s,
3H, OCH3); 4.45 (t, 1H, CH); 5.12 (t, 1H, CH); 6.92 (t,
1H, Ar/H); 7.2 (t, 2H, Ar/H); 7.41 (d, 2H, Ar/H, BP);
7.52 (t, 1H, Ar/H, BP); 7.64 (t, 2H, Ar/H, BP); 7.72 (d,
2H, Ar/H); 7.79 (d, 4H, Ar/H, BP).
IR (Nujol): n (cm1): 1742 (CO); 1280 (NO).
5.1.12. Synthesis of 2-(4-methoxyphenyl)-3-biphenyl-5-
cyano isoxazolidine (3b(i))
This was obtained from equimolar mixture of C -(4-
biphenyl)-N -(4-methoxyphenyl)nitrone (2b) (500 mg)
and acrylonitrile (0.31 mL).
1H-NMR d (ppm): 2.82/3.0 (dd, 2H, H4); 3.76 (s, 3H,
Ar/OCH3); 4.44 (t, 1H, H5); 5.06 (t, 1H, H3); 7.28 (d,
2H, Ar/H); 7.42 (d, 2H, Ar/H(BP); 7.52 (t, 1H, Ar/
H(BP); 7.63 (t, 2H, Ar/H(BP); 7.68 (d, 2H, Ar/H); 7.74
(d, 4H, Ar/H(BP).
IR (Nujol): n (cm1): 1748 (CO); 1278 (NO).
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5.1.13. Synthesis of 2-(4-methoxyphenyl)-3-biphenyl-5-
phenyl isoxazolidine (3b(ii))
This was obtained from equimolar mixture of C -(4-
biphenyl-N -(4-methoxyphenyl)nitrone (2b) (500 mg)
and styrene (0.25 mL).
1H-NMR d (ppm): 2.74/2.92 (dd, 2H, H4); 3.80 (s,
3H, Ar/OCH3); 5.04 (t, 1H, H5); 5.13 (t, 1H, H3); 7.28/
7.40 (m, 5H, Ar/H); 7.28 (d, 2H, Ar/H); 7.68 (d, 2H,
Ar/H); 7.42 (d, 2H, Ar/H(BP); 7.54 (t, 1H, Ar/H(BP);
7.64 (t, 2H, Ar/H(BP); 7.72 (d, 4H, Ar/H(BP).
IR (Nujol): n (cm1): 1712 (CO); 1246 (NO).
5.1.14. Synthesis of 2-(4-methoxyphenyl)-3-biphenyl-5-
benzoate isoxazolidine (3b(iii))
This was obtained from equimolar mixture of C -(4-
biphenyl)-N -(4-methoxyphenyl)nitrone (2b) (500 mg)
and vinyl benzoate (0.26 mL).
1H-NMR d (ppm): 2.74/2.92 (dd, 2H, H4); 3.78 (s,
3H, Ar/OCH3); 4.74 (t, 1H, H5); 5.14 (t, 1H, H3); 7.26/
7.50 (m, 3H, Ar/H); 7.28 (d, 2H, Ar/H); 7.63 (t, 2H,
Ar/H(BP) 7.70 (d, 2H, Ar/H); 7.42 (d, 2H, Ar/H(BP);
7.52 (t, 1H, Ar/H(BP); 7.68 (d, 2H, Ar/H); 7.74 (d, 4H,
Ar/H(BP).
IR (Nujol): n (cm1): 1752 (C/O); 1732 (CO); 1270
(NO).
5.1.15. Synthesis of 2-(4-methoxyphenyl)-3-biphenyl-5-
ethylate isoxazolidine (3b(iv))
This was obtained from equimolar mixture of C -(4-
biphenyl-N -(4-methoxyphenyl)nitrone (2b) (500 mg)
and ethyl acrylate (0.17 mL).
1H-NMR d (ppm): 0.94 (t, 3H, CH3); 2.68/2.85 (dd,
2H, H4); 3.62 (q, 2H, CH2); 3.78 (s, 3H, Ar/OCH3);
4.45 (t, 1H, H5); 5.13 (t, 1H, H3); 7.28 (d, 2H, Ar/H);
7.42 (d, 2H, Ar/H(BP); 7.52 (t, 1H, Ar/H(BP); 7.63 (t,
2H, Ar/H(BP); 7.68 (d, 2H, Ar/H); 7.74 (d, 4H, Ar/
H(BP).
IR (Nujol): n (cm1): 1726 (C/O); 1708 (CO); 1240
(NO).
5.1.16. Synthesis of 2-(4-methoxyphenyl)-3-biphenyl-5-
methylene acetate isoxazolidine (3b(v))
This was obtained from equimolar mixture of C -(4-
biphenyl)-N -(4-methoxyphenyl)nitrone (2b) (500 mg)
and allyl acetate (0.23 mL).
1H-NMR d (ppm): 2.42 (d, 2H, CH2); 2.67/2.85 (dd,
2H, H4); 3.42 (s, 3H, OCH3); 3.76 (s, 3H, Ar/OCH3);
4.26 (t, 1H, H5); 5.12 (t, 1H, H3); 7.26 (d, 2H, Ar/H);
7.42 (d, 2H, Ar/H(BP); 7.50 (t, 1H, Ar/H(BP); 7.62 (t,
2H, Ar/H(BP); 7.68 (d, 2H, Ar/H); 7.70 (d, 4H, Ar/
H(BP).
IR (Nujol): n (cm1): 1720 (CO); 1250 (NO).
5.1.17. Synthesis of 2-(4-methoxyphenyl)-3-biphenyl-
5metylene hydroxy isoxazolidine (3b(vi))
This was obtained from equimolar mixture of C -(4-
biphenyl)-N -(4-methoxyphenyl)nitrone (2b) (500 mg)
and allyl alcohol (0.24 mL).
1H-NMR d (ppm): 2.66/2.84 (dd, 2H, H4); 3.63 (d,
2H, CH2); 3.78 (s, 3H, Ar/OCH3); 4.74 (t, 1H, H5); 5.12
(t, 1H, H3); 5.25 (s, 1H, OH); 7.26 (d, 2H, Ar/H); 7.42
(d, 2H, Ar/H(BP); 7.52 (t, 1H, Ar/H(BP); 7.63 (t, 2H,
Ar/H(BP); 7.68 (d, 2H, Ar/H); 7.74 (d, 4H, Ar/H(BP).
IR (Nujol): n (cm1): 1728 (CO); 1262 (NO).
5.1.18. Synthesis of 2-(4-methoxyphenyl)-3-biphenyl-5-
(3-cyclohexene) isoxazolidine (3b(vii))
This was obtained from equimolar mixture of C -(4-
biphenyl)-N -(4-methoxyphenyl)nitrone (2b) (500 mg)
and 4-vinyl-1-cyclohexene (0.21 mL).
1H-NMR d (ppm): 1.37/1.41 (m, 2H, CH2, cyclohex-
ene); 1.52 (s, 1H, cyclohexene); 2.26/2.30 (m, 2H,
cyclohexene); 2.32/2.36 (m, 2H, cyclohexene); 2.68/
2.86 (dd, 2H, H4); 3.76 (s, 3H, Ar/OCH3) 4.82 (m,
1H, H5); 5.12 (t, 1H, H3); 5.60/5.68 (m, 2H, cyclohex-
ene); 7.28 (d, 2H, Ar/H); 7.42 (d, 2H, Ar/H, BP); 7.52
(t, 1H, Ar/H, BP); 7.63 (t, 2H, Ar/H, BP); 7.68 (d, 2H,
Ar/H); 7.79 (d, 4H, Ar/H, BP).
IR (Nujol): n (cm1):1744 (CO); 1270 (NO).
5.1.19. Synthesis of 2-(4-methoxyphenyl)-3-biphenyl-5-
methylate isoxazolidine (3b(viii))
This was obtained from equimolar mixture of C -(4-
biphenyl-N -(4-methoxyphenyl)nitrone (2b) (500 mg)
and methyl acrylate (0.17 mL).
1H-NMR d (ppm): 2.66/2.84 (dd, 2H, H4); 3.42 (s,
3H, OCH3); 3.80 (s, 3H, Ar/OCH3); 4.44 (t, 1H, H5);
5.14 (t, 1H, H3); 7.28 (d, 2H, Ar/H); 7.42 (d, 2H, Ar/H,
BP); 7.52 (t, 1H, Ar/H, BP); 7.63 (t, 2H, Ar/H, BP);
7.68 (d, 2H, Ar/H); 7.79 (d, 4H, Ar/H, BP).
IR (Nujol): n (cm1): 1726 (C/O); 1708 (CO); 1240
(NO).
5.1.20. Synthesis of 2-(4-fluorophenyl)-3-biphenyl-5-
cyano isoxazolidines (3c(i))
It was obtained from equimolar mixture of C -(4-
biphenyl)-N -(4-fluorophenyl)nitrone (2c) (500 mg) and
acrylonitrile (0.30 mL).
1H-NMR d (ppm): 2.83/3.01 (q, 2H, H4); 4.46 (t, 1H,
H5); 5.10 (t, 1H, H3); 7.28 (d, 2H, Ar/H); 7.41 (d, 2H,
Ar/H(BP); 7.52 (t, 1H, Ar/H(BP); 7.64 (t, 2H, Ar/
H(BP); 7.77 (d, 2H, Ar/H); 7.69 (d, 4H, Ar/H(BP).
IR (Nujol): n (cm1): 1734 (CO); 1274 (NO).
5.1.21. Synthesis of 2-(4-fluorophenyl)-3-biphenyl-5-
phenyl isoxazolidines (3c(ii))
It was obtained from equimolar mixture of C -(4-
biphenyl)-N -(4-fluorophenyl)nitrone (2c) (500 mg) and
styrene (0.25 mL).
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1H-NMR d (ppm): 2.88/3.06 (q, 2H, H4); 5.05 (t, 1H,
H5); 5.14 (t, 1H, H3); 7.29 (d, 2H, Ar/H); 7.29/7.41 (m,
5H, Ar/H); 7.42 (d, 2H, Ar/H(BP); 7.52 (t, 1H, Ar/
H(BP); 7.64 (t, 2H, Ar/H(BP); 7.77 (d, 2H, Ar/H); 7.79
(d, 4H, Ar/H(BP).
IR (Nujol): n (cm1): 1700 (CO); 1240 (NO).
5.1.22. Synthesis of 2-(4-fluorophenyl)-3-biphenyl-5-
benzoate isoxazolidines (3c(iii))
It was obtained from equimolar mixture of C -(4-
biphenyl)-N -(4-fluorophenyl)nitrone (2c) (500 mg) and
vinyl benzoate (0.15 mL).
1H-NMR d (ppm)): 2.85/3.03 (q, 2H, H4); 4.72 (t,
1H, H5); 5.15 (t, 1H, H3); 7.28 (d, 2H, Ar/H); 7.29/7.50
(m, 3H, Ar/H); 7.42 (d, 2H, Ar/H, BP); 7.53 (t, 1H,
Ar/H, BP); 7.64 (t, 2H, Ar/H, BP); 7.78 (d, 2H, Ar/
H); 7.79 (d, 4H, Ar/H, BP). 7.81 (d, 2H, Ar/H).
IR (Nujol): n (cm1): 1738 (C/O); 1730 (CO); 1268
(NO).
5.1.23. Synthesis of 2-(4-fluorophenyl)-3-biphenyl-5-
ethylate isoxazolidines (3c(iv))
It was obtained from equimolar mixture of C -(4-
biphenyl)-N -(4-fluorophenyl)nitrone (2c) (500 mg) and
ethyl acrylate (0.21 mL).
1H-NMR d (ppm): 0.93 (t, 3H, CH3); 2.84/3.02 (q,
2H, H4); 3.62 (q, 2H, CH2); 4.44 (t, 1H, H5); 5.13 (t, 1H,
H3); 7.28 (d, 2H, Ar/H); 7.41 (d, 2H, Ar/H, BP); 7.52
(t, 1H, Ar/H, BP); 7.64 (t, 2H, Ar/H, BP); 7.77 (d, 2H,
Ar/H); 7.79 (d, 4H, Ar/H, BP).
IR (Nujol): n (cm1): 1722 (C/O); 1700 (CO); 1232
(NO).
5.1.24. Synthesis of 2-(4-fluorophenyl)-3-biphenyl-5-
methylene acetate isoxazolidines (3c(v))
It was obtained from equimolar mixture of C -(4-
biphenyl)-N -(4-fluorophenyl)nitrone (2c) (500 mg) and
allyl acetate (0.1 mL).
1H-NMR d (ppm): 2.42 (d, 2H, CH2); 2.84/3.02 (q,
2H, H4); 3.42 (s, 3H, OCH3); 4.26 (t, 1H, H5); 5.12 (t,
1H, H3); 7.26 (d, 2H, Ar/H); 7.41 (d, 2H, Ar/H, BP);
7.52 (t, 1H, Ar/H, BP); 7.64 (t, 2H, Ar/H, BP); 7.77 (d,
2H, Ar/H); 7.79 (d, 4H, Ar/H, BP).
IR (Nujol): n (cm1): 1740 (CO); 1266 (NO).
5.1.25. Synthesis of 2-(4-fluorophenyl)-3-biphenyl-5-
methylene hydroxy isxazolidine (3c(vi))
It was obtained from equimolar mixture of C -(4-
biphenyl)-N -(4-fluorophenyl)nitrone (2c) (500 mg) and
allyl alcohol (0.15 mL).
1H-NMR d (ppm): 2.74/2.92 (q, 2H, H4); 3.64 (d,
2H, CH2); 4.76 (t, 1H, H5); 5.12 (t, 1H, H3); 5.25 (s, 1H,
OH); 7.28 (d, 2H, Ar/H); 7.41 (d, 2H, Ar/H, BP); 7.52
(t, 1H, Ar/H, BP); 7.64 (t, 2H, Ar/H, BP); 7.77 (d, 2H,
Ar/H); 7.79 (d, 4H, Ar/H, BP).
IR (Nujol): n (cm1): 1720 (CO); 1248 (NO).
5.1.26. Synthesis of 2-(4-fluorophenyl)-3-biphenyl-5-(3-
cyclohexene) isoxazolidines (3c(vii))
It was obtained from equimolar mixture of C -(4-
biphenyl)-N -(4-fluorophenyl)nitrone (2c) (500 mg) and
4-vinyl-1-cyclohexene (0.25 mL).
1H-NMR d (ppm): 1.38/1.42 (m, 2H, CH2, cyclohex-
ene); 1.52 (s, 1H, cyclohexene); 2.28/2.31 (m, 2H,
cyclohexene); 2.33/2.38 (m, 2H, cyclohexene); 2.85/
3.03 (q, 2H, H4); 4.82 (m, 1H, CH); 5.14 (t, 1H, H3);
5.6/5.66 (m, 2H, cyclohexene); 7.28 (d, 2H, Ar/H); 7.41
(d, 2H, Ar/H, BP); 7.52 (t, 1H, Ar/H, BP); 7.63 (t, 2H,
Ar/H, BP); 7.77 (d, 2H, Ar/H); 7.79 (d, 4H, Ar/H,
BP).
IR (Nujol): n (cm1): 1730 (CO); 1260 (NO).
5.1.27. Synthesis of 2-(4-fluorophenyl)-3-biphenyl-5-
ethyl isoxazolidines (3c(viii))
It was obtained from equimolar mixture of C -(4-
biphenyl)-N -(4-fluorophenyl)nitrone (2c) (500 mg) and
methyl acrylate (0.35 mL).
1H-NMR d (ppm): 2.87/3.05 (q, 2H, H4); 3.41 (s, 3H,
OCH3); 4.45 (t, 1H, H5); 5.12 (t, 1H, H3); 7.28 (d, 2H,
Ar/H); 7.41 (d, 2H, Ar/H, BP); 7.52 (t, 1H, Ar/H,
BP); 7.64 (t, 2H, Ar/H, BP); 7.77 (d, 2H, Ar/H); 7.79
(d, 4H, Ar/H, BP).
IR (Nujol): n (cm1): 1745 (CO); 1278 (NO).
5.2. Determination of antifungal activity
Fungus used for the antifungal activity: Aspergillus
flavus (ATCC76087) Fusarium moniliforme
(ATCC5342) Botrydiplodia theobromae (ATCC76087)
The isoxazolidines were tested for antifungal activity
by serial tube dilution technique [13,14] at different
concentrations (0.5, 1, 1.5, . . ., 12 mM) against A.
flavus , F. moniliforme and B. theobromae . Nystatin
was used as reference standard and CHCl3 as control.
To the culture tubes containing 1.9 mL of media, 0.1 mL
of test solution was added at sterile conditions. To all
the tubes including standard and controls, the fresh
inoculum was added using Himedia flexiloop 4 cali-
brated to 0.001 mL. After incubating all the tubes at
37 8C for 24 h, their absorbance was recorded at 640 nm
along with Nystatin. Percentage of inhibition was
calculated as by the following equation,
% Inhibition
100 (PQ)
P
where P/absorbance without the test sample and Q/
absorbance with test sample.
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